BIOLASE Technology (BLIT) Receives FDA 510(k) Clearance
Tweet
Share
E-mailGet Alerts BLTI Hot Sheet
Join SI Premium – FREE
BIOLASE Technology, Inc. (Nasdaq: BLTI) received 510(k) clearance from the FDA allowing it to market a version of its Waterlase MD Laser System for use in dermatological applications as well as general and plastic surgery.
You May Also Be Interested In
- Seagate board member Arumugavelu to step down at annual meeting
- Intel (INTC) PT Lowered to $92 at Mizuho
- GLJ Research on Tesla (TSLA): 'Sell-the-news'
Create E-mail Alert Related Categories
Retail SalesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
